Skip to main content
. Author manuscript; available in PMC: 2018 Oct 19.
Published in final edited form as: Adv Funct Mater. 2017 Aug 21;27(39):1703261. doi: 10.1002/adfm.201703261

Figure 3.

Figure 3

(A) DOX loading efficiency of PEG-TaS2 NSs. The insert shows the picture of aqueous dispersions of PEG-TaS2 NSs with increased DOX loading efficiency. (B) DOX release from PEG-TaS2 NSs under different conditions. (C) Cell viability of PC3 cells after treatment with various groups. (D) Western blot analysis of phospho-p38 (p-p38) and p38 expression in PC3 cells after treatments with various groups.